VoxCell BioInnovation
VoxCell BioInnovation is a forward-thinking biotechnology company specializing in 3D, vascularized bioprinted tissue models for preclinical cancer drug screening. Using high-resolution bioprinting technology, advanced vascularization software, and proprietary Universal Bioinks™, VoxCell creates human-like cancer tissue models that replicate the complex tumor microenvironment. Our flagship product is a 3D model of Triple Negative Breast Cancer (TNBC), offering pharmaceutical companies, biotech firms, CROs, and academic institutions a more accurate, predictive platform for drug testing and target identification.